R1 RCM Inc.
RCM
Rangering i aksjer
#3056
R1 RCM Inc. leverages technology to provide solutions that both optimize the... R1 RCM Inc. leverages technology to provide solutions that both optimize the patient experience and bolster the financial performance of hospitals, health systems, and medical groups. Its core offering is comprehensive revenue cycle management (RCM), meticulously designed to address the entire spectrum of financial complexities faced by healthcare providers. Beyond this holistic approach, R1 RCM also delivers flexible, specialized solutions. These encompass physician advisory services, guiding healthcare organizations on compliant classification of hospital visits (in-patient versus out-patient observation) for billing purposes. Additional modular services include: Practice management: Offering administrative and operational support to streamline patient care, alongside outsourcing of non-essential functions. Revenue integrity: Encompassing critical elements like accurate charge capture, meticulous maintenance of the charge description master, and strategic pricing services. Coding management: Featuring business intelligence and analytical insights, human capital management, robust accountability frameworks, and quality assurance programs. Patient experience enhancements. Business office support. Furthermore, the company provides cloud-based (SaaS) platforms for scheduling and improving patient access. R1 RCM Inc. was established in 2003 and is headquartered in Murray, Utah.
Aksjekurs
$14.31
Sist synkronisert: 2024-11-20
Markedsverdi
$5.97B
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel R1 RCM Inc. (RCM)
Kategori
Healthcare
P/B-forhold for R1 RCM Inc. (RCM)
P/B-forhold per October 2026 TTM: 2.18
Ifølge R1 RCM Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 2.18. Ved slutten av 2022 hadde selskapet et P/B-forhold på 1.42.
P/B-historikk for R1 RCM Inc. fra 2007 til 2026
P/B-forhold ved hvert års slutt
| År | P/B-forhold | Endre |
|---|---|---|
| 2026 (TTM) | 2.18 | 35.22% |
| 2023 | 1.61 | 13.39% |
| 2022 | 1.42 | -92.75% |
| 2021 | 19.57 | 138.94% |
| 2020 | 8.19 | -89.76% |
| 2019 | 79.96 | -40.96% |
| 2018 | 135.44 | 901.16% |
| 2017 | 13.53 | -161.70% |
| 2016 | -21.93 | 1,689.42% |
| 2015 | -1.23 | -32.59% |
| 2014 | -1.82 | -39.77% |
| 2013 | -3.02 | 167.75% |
| 2012 | -1.13 | -202.50% |
| 2011 | 1.10 | -17.82% |
| 2010 | 1.34 | -71.28% |
| 2009 | 4.66 | -62.99% |
| 2008 | 12.59 | 100.81% |
| 2007 | 6.27 | 0.00% |
P/B-forhold for lignende selskaper eller konkurrenter
| Selskap | P/B-forhold | Forskjell i P/B-forhold | Land |
|---|---|---|---|
| 2.8261 | 29.81% |
US
|
|
| 37.8989 | 1,640.80% |
AU
|
|
| 6.3712 | 192.65% |
US
|
|
| 27.6264 | 1,168.95% |
US
|
|
| 11.5098 | 428.68% |
US
|
